References
- Chapman-Smith JS. Cryptococcal chorioretinitis: A case report. Br J Ophthalmol. 1977;61:411–413.
- Wykoff CC, Albini TA, Couvillion SS, et al. Intraocular cryptococcoma. Arch Ophthalmol. 2009;127:700–702.
- Crump JR, Elner SG, Elner VM, et al. Cryptococcal endophthalmitis: Case report and review. Clin Infect Dis. 1992;14:1069–1073.
- Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50:291–322.
- Hiss PW, Shields JA, Augsburger JJ. Solitary retinovitreal abscess as the initial manifestation of cryptococcosis. Ophthalmology. 1988;95:162–165.
- Vela JI, Diaz-Cascajosa J, Sanchez F, et al. Management of endogenous cryptococcal endophthalmitis with voriconazole. Can J Ophthalmol. 2009;44:e61–e62.
- Sheu SJ, Chen YC, Kuo NW, et al. Endogenous cryptococcal endophthalmitis. Ophthalmology. 1998;105:377–381.
- Malton ML, Rinkoff JS, Doft BS, et al. Cryptococcal endophthalmitis and meningitis associated with acute psychosis and exudative retinal detachment. Am J Ophthalmol. 1987;104:438–439.
- van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD. Effects of voriconazole on Cryptococcus neoformans. Antimicrob Agents Chemother. 2004;48:2014–2020.
- Shields JA, Wright DM, Augsburger JJ, et al. Cryptococcal chorioretinitis. Am J Ophthalmol. 1980;89(2):210–217.
- Nakamura S, Izumikawa K, Seki M, et al. Reversible visual disturbance due to cryptococcal uveitis in a non-HIV individual. Med Mycol. 2008;46(4):367–370.